Lupin launches generic Ortho Tri-Cyclen Lo

MUMBAI and BALTIMORE — Lupin Pharmaceuticals announced Wednesday that it had launched its Tri-Lo-Marzia (norgestimate and ethinyl estradiol) tablets, a generic version of Jannsen’s Ortho Tri-Cyclen Lo. The drug is indicated to prevent pregnancy in women. 

 

Ortho Tri-Cyclen Lo saw about $488.4 million in sales in the 12 months ending September 2015, according to IMS Health. This is Lupin’s 16th contraceptive launch in the United States.